Factors of cardiovascular risk in patients with type 2 diabetes and incipient nephropathy

Hippokratia

Volumn 12, Issue 4, 2008, Pages 221-224

  Nelaj, Ergita ^a   Gjata, M ^a   Lilaj, I ^a   Burazeri, G ^b   Sadiku, E ^a   Collaku, L ^a   Bare, O ^a   Tase, M ^a  

^a UHC Mother Teresa Tirane ^*  (Albania)

^b University of Tirana Faculty of Medicine   (Albania)

Author keywords

Cardiovascular risk; Microalbuminuria; Nephropathy; Type 2 diabetes

Indexed keywords

HEMOGLOBIN A1C;

ADULT; AGED; ARTERY INTIMA PROLIFERATION; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DISEASE DURATION; FEMALE; HEART LEFT VENTRICLE MASS; HUMAN; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREVALENCE; RISK FACTOR;

EID: 53849122013     PISSN: 11084189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. American Diabetes Assocation. Screening for type 2 diabetes. Diabetes Care 2000; 23 (Suppl): S20-S23
2. Boronat M, Varillas VF, Saavedra P, et al. Diabetes mellitus and impaired glucose regulation in the Canary Islands (Spain): prevalence and associated factors in the adult population of Telde, Gran Canaria. Diabet Med 2006; 23; 148-155
3. Almdal T, Scharling H, Jensen JS, Vestergaard H. The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death: a population-based study of 13,000 men and women with 20 years of follow-up. Arch Intern Med 2004; 164: 1422-1426
4. Stamler J. Impact of Diabetes on Cardiovascular Mortality in MRFIT. Diabetes Care 1993; 15: 434-444
5. American Diabetes Assocation, Cardiovascular risk factors and disease management in type 2 diabetes with diabetic nephropathy. Diabetes Care 2006; 29: 498-503
6. Parving HH, Lewis JB, Ravid M, Remuzzi G, Hunsicker LG. DEMAND investigators. Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: a global perspective. Kidney Int 2006; 69: 2057-2063
7. Ruggenenti P, Remuzzi G. Nephropathy of type-2 diabetes mellitus. J Am Soc Nephrol 1998; 9: 2157-2169
8. Al-Shaikh A. Prevalence of microalbuminuria in type 2 diabetes mellitus at a diabetic clinic in King Abdulaziz University Hospital. Pak J Med Sci 2007; 23: 223-226
9. Morrish NJ, Wang SL, Stevens LK, Fuller JH, Keen H. Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes. Diabetologia 2001; 44 (Suppl 2): S14-S21
10. Cea-Calvo L, Conthe P, Gómez-Fernández P, de Alvaro F, Fernández-Pérez C; RICARHD investigators. Target organ damage and cardiovascular complications in patients with hypertension and type 2 diabetes in Spain: a cross-sectional study. Cardiovasc Diabetol 2006; 5: 23
11. Keller CK, Bergis KH, Fliser D, Ritz E. Renal findings in patients with short-term type 2 diabetes. J Am Soc Nephrol 1996; 12: 2627-2635
12. Charpentier G,Genes N,Vaur L, et al; Control of diabetes and cardiovascular risk factors in patients with type 2 diabetes: a nationwide French survey. Diabetes Metab 2003; 29: 152-158
13. Dries DL, Sweitzer NK, Drazner MH, Stevenson LW, Gersh BJ. Prognostic impact of diabetes mellitus in patients with heart failure according to the etiology of left ventricular systolic dysfunction. J Am Coll Cardiol 2001; 38: 421-428
14. Sowers JR, Epstein M, Frohlich ED. Diabetes, hypertension, and cardiovascular disease: an update. Hypertension 2001; 37: 1053-1059
15. Epstein M, Sowers JR. Diabetes mellitus and hypertension. Hypertension 1992; 19: 403-418
16. Mudríková T, Szabová E, Tkác I. Carotid intima-media thickness in relation to macrovascular disease in patients with type 2 diabetes mellitus. Wien Klin Wochenschr 2000; 112: 887-891
17. Guerci B, Böhme P, Kearney-Schwartz A, Zannad F, Drouin P. Endothelial dysfunction and type 2 diabetes. Part 2: altered endothelial function and the effects of treatments in type 2 diabetes mellitus. Diabetes Metab 2001; 27(4 Pt 1): 436-447
18. Liu JE, Palmieri V, Roman MJ, et all. The impact of diabetes on left ventricular filling pattern in normotensive and hypertensive adults: the Strong Heart Study. J Am Coll Cardiol 2001; 37: 1943-1949
19. Hiller R, Sperduto RD, Podgor MJ, Ferris FL 3rd, Wilson PW. Diabetic retinopathy and cardiovascular disease in type II diabetics. The Framingham Heart Study and the Framingham Eye Study. Am J Epidemiol 1988; 128: 402-409.
20. Frank RN. Diabetic retinopathy. N Engl J Med 2004; 350: 48-58
21. van Hecke MV, Dekker JM, Stehouwer CD, et al; EURODIAB prospective complications study.Diabetic retinopathy is associated with mortality and cardiovascular disease incidence: the EURODIAB prospective complications study. Diabetes Care 2005; 28: 1383-1389
22. Ridderstr?le M, Gudbjörnsdottir S, Eliasson B, Nilsson PM, Cederholm J; Steering Committee of the Swedish National Diabetes Register (NDR).Obesity and cardiovascular risk factors in type 2 diabetes: results from the Swedish National Diabetes Register. J Intern Med 2006; 259: 314-322
23. Ismail N, Becker B, Strzelczyk P, Ritz E.Renal disease and hypertension in non-insulin-dependent diabetes mellitus. Kidney Int 1999; 55: 1-28
24. Adler AI, Stevens RJ, Manley SE, et al.Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int 2003; 63: 225-232
25. Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003; 348: 383-393
26. Khaw KT, Wareham N, Bingham S, Luben R, Welch A, Day N. Association of hemoglobin A1c with cardiovascular disease and mortality inadults: the European prospective investigation into cancer in Norfolk. Ann Intern Med 2004; 141: 413-420